Ascendis Pharma A (ASND) Current Leases (2019 - 2023)

Ascendis Pharma A (ASND) has 5 years of Current Leases data on file, last reported at $15.3 million in Q4 2023.

• For the quarter ending Q4 2023, Current Leases rose 8.59% year-over-year to $15.3 million; the trailing twelve-month figure through Dec 2023 stood at $15.3 million (up 8.59% YoY), and the FY2023 full-year result was $15.4 million, up 5.68% from the prior year.
• Current Leases grew to $15.3 million in Q4 2023, from $14.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $15.3 million in Q4 2023 to a low of $6.5 million in Q4 2019.
• A 5-year average of $10.4 million and a median of $8.2 million in 2020 frame the typical range for Current Leases.
• Across the five-year window, Current Leases retreated 2.15% in 2021 and surged 75.83% in 2022, its largest moves.
• Tracing ASND's Current Leases over 5 years: stood at $6.5 million in 2019, then advanced by 25.25% to $8.2 million in 2020, then slipped by 2.15% to $8.0 million in 2021, then surged by 75.83% to $14.1 million in 2022, then increased by 8.59% to $15.3 million in 2023.
• Business Quant data shows ASND's Current Leases at $15.3 million in Q4 2023, $14.1 million in Q4 2022, and $8.0 million in Q4 2021.